Healthcare Startup Grows 2,805 Percent In 7 Years With CPAP Sanitizer

No one wants to use a CPAP machine. But millions of people have no choice in order to deal with obstructive sleep apnea, a serious condition that causes sufferers to stop breathing while they sleep. Sleep apnea is associated with heart disease, high blood pressure, type 2 diabetes and other conditions. SoClean developed the first… Read More: Healthcare Startup Grows 2,805 Percent In 7 Years With CPAP… »

Well: War Wounds That Time Alone Can’t Heal

Video “Almost Sunrise” In a clip from “Almost Sunrise,” Katinka Hooyer, a medical anthropologist and postdoctoral research fellow in Family and Community Medicine at the Medical College of Wisconsin, talks about the meaning of love and feeling moral pain. By THOUGHTFUL ROBOT PRODUCTIONS on Publish Date June 5, 2016. embed No doubt in the course… Read More: Well: War Wounds That Time Alone Can’t Heal »

6 Major Ways the 'Avengers: Endgame' Trailer Is Lying to Us

We’re not entirely sure who to blame, but basically every single Marvel trailer since Iron Man 3 has told us a massive lie. Whether it’s that thrilling shot of Spider-Man and Iron Man flying together (that wasn’t actually in Homecoming), or the Infinity War money-shot of everyone running to the camera (that also didn’t make… Read More: 6 Major Ways the 'Avengers: Endgame' Trailer Is Lying to… »

FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma

Print this page KENILWORTH, N.J.–(BUSINESS WIRE) December 19, 2018 –Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC), based… Read More: FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with… »